NASDAQ (USD): Aptose Biosciences Inc. (APTO)
Last Price
0.249
Today's Change
+0.079 (46.47%)
Day's Change
0.211 - 0.39
Trading Volume
289,668,391
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
Trump Transition Team Plans Sweeping Rollback of Biden's EV, Emissions Policies
2
Nasdaq Tops NYSE in Listings for Sixth Straight Year as IPO Optimism Grows
3
Goldman Sachs Economists See Fed Skipping a Rate Cut in January
4
Cocoa Soars to Fresh Record in Blow to World’s Chocolate Supply
5
TikTok Turns to US Supreme Court in Last-ditch Bid to Avert Ban
#
Stock
Score
AADI
Aadi Bioscience, Inc.
APTO
Aptose Biosciences Inc.
TNXP
Tonix Pharmaceuticals Holding Corp.
BABA
Alibaba Group Holding Limited
800
GOOGL
Alphabet Inc.
750
6
VRAX
Virax Biolabs Group Limited
7
HSBC
HSBC Holdings plc
500
8
PLTR
Palantir Technologies Inc.
9
AGN
10
RGTI
Rigetti Computing, Inc.
Last
Change
Volume
+0.079
EDBL
0.285
+0.139
267,211,468
0.591
+0.021
225,861,800
LICN
0.489
-1.631
183,350,854
9.47
+2.00
167,364,247
NVDA
133.84
+3.16
155,502,398
TAOP
0.419
+0.102
134,313,661
QUBT
15.14
-10.54
120,604,778
LMDX
0.016
-0.018
120,553,903
MYSZ
4.37
+3.01
113,323,555
BRK-A
682,715.52
+9,441.50
1,038
NVR
8,240.82
+139.61
15,960
BKNG
5,054.59
+74.19
133,780
MELI
1,720.62
+54.62
413,318
FCNCA
2,111.92
+40.98
36,237
AZO
3,252.77
+37.48
77,447
SEB
2,486.19
+32.29
1,519
FNGU
627.45
+31.05
724,642
WTM
1,914.25
+29.59
7,506
LLY
784.42
+26.88
5,623,390
1,774.05
-343.25
2,940,447
MSTR
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
NOW
643.29
-87.83
5,025,012
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
RYVLX
562.73
-43.79
0
RYVYX
562.54
-43.78
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....